Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines
- PMID: 1904907
- DOI: 10.1007/BF02924542
Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines
Abstract
The antiproliferative effects of natural human tumor necrosis factor-alpha (nHuTNF-alpha), natural human interferon-alpha (nHuIFN-alpha), and natural human interferon-gamma (nHuIFN-gamma) were investigated in human pancreatic carcinoma cell lines. HuP-T3, HuP-T4, and BxPC-3 carcinoma cells exhibited mild growth inhibition after treatment with nHuTNF-alpha. HuP-T3, HuP-T4, MIA-PaCa-2, and BxPC-3 cells exhibited mild or marked growth inhibition after treatment with nHuIFN-alpha. Incubation with nHuIFN-gamma caused marked growth inhibition of HuP-T4 and BxPC-3 cells, whereas HuP-T1, HuP-T3, and MIA-PaCa-2 cells showed only mild growth inhibition with the same dose of nHuIFN-gamma. Combined nHuTNF-alpha and nHuIFN-alpha (1:1) demonstrated marked synergism in comparison with their effects as single agents on HuP-T1, HuP-T3, and MIA-PaCa-2 cells. The combination of nHuTNF-alpha and nHuIFN-gamma (100:1) also demonstrated a marked synergistic effect in comparison with these cytokines alone in four out of five pancreatic carcinoma cell lines (HuP-T1, HuP-T3, HuP-T4, and MIA-PaCa-2 cell lines). The marked increase in efficacy brought about by using combinations of cytokines may enable some improvement in the treatment of pancreatic carcinoma patients in the future.
Similar articles
-
Synergistic antitumor effects of natural human tumor necrosis factor-alpha and natural human interferon-alpha or -gamma on human cancer cell lines.Res Commun Chem Pathol Pharmacol. 1989 Apr;64(1):87-97. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2501839
-
Therapeutic potential of natural human tumor necrosis factor-alpha in combination with natural human interferon-alpha or -gamma on human cancer cells.Res Commun Chem Pathol Pharmacol. 1988 Sep;61(3):345-51. Res Commun Chem Pathol Pharmacol. 1988. PMID: 3141998
-
Synergistic interaction of natural human tumor necrosis factor-alpha/natural human interferon-alpha mixture alone and in combination with cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.Auris Nasus Larynx. 1993;20(1):53-62. doi: 10.1016/s0385-8146(12)80211-2. Auris Nasus Larynx. 1993. PMID: 8323491
-
Antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha in combination against human cancer transplanted into nude mice.Acta Med Okayama. 1989 Aug;43(4):211-21. doi: 10.18926/AMO/30855. Acta Med Okayama. 1989. PMID: 2801185
-
Synergistic effect of tumor necrosis factor-alpha and interferon-alpha on the induction of apoptosis detected by BM-1/JIMRO: a new marker of apoptosis.Acta Med Okayama. 1994 Feb;48(1):51-5. doi: 10.18926/AMO/31134. Acta Med Okayama. 1994. PMID: 8191917
Cited by
-
Development of gene therapy to target pancreatic cancer.Cancer Sci. 2004 Apr;95(4):283-9. doi: 10.1111/j.1349-7006.2004.tb03204.x. Cancer Sci. 2004. PMID: 15072584 Free PMC article. Review.
-
Systemic use of tumor necrosis factor alpha as an anticancer agent.Oncotarget. 2011 Oct;2(10):739-51. doi: 10.18632/oncotarget.344. Oncotarget. 2011. PMID: 22036896 Free PMC article. Review.
-
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines.Br J Cancer. 1994 May;69(5):826-32. doi: 10.1038/bjc.1994.161. Br J Cancer. 1994. PMID: 8180010 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical